Nucleai
Yuval Gabay began their work experience in 2006 as a Developer at NPX/Fraud Sciences. They then moved on to work as a Research Developer at PayPal's Risk Management division in 2008. From 2012 to 2018, Gabay worked as a Research Developer at Deep Sciences, SW Ventures. In 2018, they joined Nucleai as a Senior Algorithm Developer, where they contributed to the development of an AI-powered precision oncology platform and collaborated with leading pharmaceutical companies.
Yuval Gabay completed their education as follows:
From 2004 to 2006, they held a post-doctoral position at the Ben-Gurion University of the Negev in the Department of Mathematics.
Between 1998 and 2004, they pursued their Ph.D. in Mathematics and M.Sc. in Computer Science at Cornell University.
From 1995 to 1998, they studied at The Hebrew University of Jerusalem, earning a B.Sc. in Mathematics and a B.Sc. in Computer Science.
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.